They are 100% focused on bringing us intuitive, patient-centric IV products and services that provide meaningful clinical differentiation, consistent innovation, and superior value. They design their products to work within our existing workflows to minimize disruption and maximize the time spent with patients.
Together, they help forge the human and emotional connections that enhance the clinical experience and are the essence of the outstanding quality of care. For more than three decades, they have been dedicated to a singular purpose—improving the safety and efficiency of IV therapy. With the acquisition of Hospira Infusion Systems from Pfizer in 2017, they became the only company to focus exclusively on IV therapy across the range of care.
